WE-REACH

WE-REACH Summer 2024 Funding Opportunity

WE-REACH is pleased to announce a Summer funding opportunity! Teams can request up to $150k in direct costs for 10-month projects to commercialize biotech products! Declarations of Intent are due by Thursday June 6th at 5pm!

For application instructions, click here: Summer 2024 RFA

For more information on the WE-REACH program, click here: Fact Sheet

 

 

 564+ Innovators Supported

165+ Employed by 20 Funded Teams

$3.2M Direct Costs Invested

More than $38.6M in Follow-On

 

 


Mission

A researcher working in the lab processing tests

-Leverage public-private partnerships to support end-to-end Innovations for health impact and access

-Accelerate the transformation of novel discoveries into innovative products

-Award milestone-driven WE-REACH R&D projects with value-added services

-Fuel the formation of sustainable start-up companies

-Train the next generation of biomedical entrepreneurs

-Serve as a national REACH innovation hub for the Pacific Northwest donation

 


 

FUNDING

Commercialization award and support

TRAINING

Programs for students and faculty

NEWS

Opportunities and announcements

EVENTS

Connect with people and resources

 


Contact us

Email:

wereach@uw.edu

Follow us on Twitter

Twitter logo

Support us

GIVE TO WE-REACH

Sign up for Newsletter

Newsletter Sign up


Our Partners

Partners are founding members or organizations providing funding and support for WE-REACH projects and initiatives.

National Institutes of Health Logo
UW Logo
Institute of Translational Health Sciences Logo
CoMotion Logo
Institute for Protein Design Logo
UW School of Pharmacy Logo

Collaborators

Collaborators provide value-add services, educational resources, technical support, project pipelines, and other opportunities to ensure the success of WE-REACH initiatives.

University of Washington School of Law logo

 

Foster school of business logo

 

Seattle Children's Logo

 

Ascend Hub logo

GIVE TO WE-REACH

WE-REACH is supported in part by NIH Grant #1 U01 HL152401-01 and partners.